Metis Global Partners, LLC
Position in TEVA — Teva Pharmaceutical Industries Ltd
CIK 1594916
San Diego, CA
Position in TEVA
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$982,486
+$254,938 QoQ
Shares Held
28,999
+20.1% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#340
of 671 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TEVA Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Metis Global Partners, LLC holds $4,199,495 across 6 Drug Manufacturers - Specialty & Generic names. TEVA ranks #2 (23.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
37,537 | $2,697,408 | |
| 2 | TEVA |
Teva Pharmaceutical Industries Ltd
This page
|
28,999 | $982,486 | |
| 3 | VTRS |
Viatris Inc
|
21,618 | $343,293 | |
| 4 | KMDA |
Kamada Ltd
|
12,479 | $91,595 | |
| 5 | SIGA |
Siga Technologies Inc
|
11,766 | $42,828 | |
| 6 | ORGO |
Organogenesis Holdings Inc.
|
17,237 | $41,885 |
All Filings in TEVA
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $982,486 | 28,999 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $727,548 | 24,155 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $697,012 | 22,333 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $328,229 | 16,249 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $258,120 | 15,401 | Shares | Sole | 2025-08-06 | |
| 2025-03-31 | $209,831 | 13,652 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $301,881 | 13,697 | Shares | Sole | 2025-02-05 | |
| 2024-09-30 | $231,322 | 12,837 | Shares | Sole | 2024-11-06 | |
| 2024-06-30 | $202,767 | 12,478 | Shares | Sole | 2024-08-06 | |
| No filing history on record for this holder in this stock. | ||||||